Simple frailty quiz may predict chemo risks in seniors
NCT ID NCT07272538
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether two easy-to-use frailty checklists (FRAIL and FiND) can predict severe side effects from chemotherapy in adults aged 65 and older with gastrointestinal cancers. Researchers followed 84 patients who had already had surgery and were receiving standard chemo. They found that higher frailty scores at the start of treatment were linked to more serious side effects, which could help doctors personalize care for older patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Etlik City Hospital Medical Oncology Department
Ankara, Yenimahalle, 06270, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Blood test score may flag High-Risk esophageal surgery patients
- Can a new drug combo shrink Hard-to-Treat tumors?
- Could essential oils tame chemo nausea? a new trial puts aromatherapy to the test